VAERS 2695815
GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 29EY3
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 13.10.2023
- Impfdatum
- 01.06.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Symptomtext
Diarrhea; Her arm hurt really bad; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 29EY3, expiry date 28-JUN-2024) for prophylaxis. Concurrent medical conditions included allergy (Cephalexin, Morphine, Codeine and Sulfa albendazole). Concomitant products included alprazolam. On 01-JUN-2023, the patient received the 1st dose of Shingrix (right deltoid). On 01-JUN-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: Her arm hurt really bad). On an unknown date, the patient experienced diarrhea (Verbatim: Diarrhea). The outcome of the pain in arm was resolved (duration 3 days) and the outcome of the diarrhea was not resolved. The reporter considered the pain in arm and diarrhea to be possibly related to Shingrix. The company considered the pain in arm and diarrhea to be possibly related to Shingrix. Additional Information: GSK Receipt Date: 31-AUG-2023 The patient was self-reported this case. The reporter reported that she received Shingrix vaccine and on same day she experienced arm hurt really bad for 3 days. The patient experienced diarrhea before receiving 2nd dose of Shingrix vaccine. The reporter consented to follow up. Follow information received on 05-OCT-2023 It was reported that patient received 2nd dose on 30th August 2023 on left deltoid with batch number 7L777 and expiry date 22 August 2025. The patient had allergies with Cephalexin which caused GI upset and diarrhea, Morphine which caused itching, Codeine which caused nausea, vomiting and Sulfa albendazole which caused nausea, vomiting. It was reported that the clinic was unaware of the adverse events occurred after 1st dose. Summary of changes: Patient tab, product tab, event tab and narrative was updated.; Sender's Comments: US-GSK-US2023AMR122939:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy (Cephalexin, Morphine, Codeine and Sulfa albendazole)
- Vorgeschichte
- -
- Andere Medikamente
- ALPRAZOLAM
- Allergien
- -
- Vorherige Impfungen
- -